Rotigotine and epistaxis Patient Reports February 12, 2012

Rotigotine Side Effects Report #6106793-X
Rotigotine side effect was reported by a Health Professional from JAPAN on Feb 16, 2009. Female patient was diagnosed with parkinson's disease  and was treated with Rotigotine. After drug was administered, patient experienced the following side effects: epistaxis. Rotigotine dosage: 4.5 MG TRANSDERMAL, 9 MG, TRANSDERMAL, 13.5 MG TRANSDERMAL. During the same period patient was treated with OMEPRAZOLE, MAGNESIUM OXIDE, ANTIFUNGALS, ETIZOLAM, NABUMETONE, KETOPROFEN. Patient was hospitalized. Patient recovered.

Rotigotine Side Effects Report #6123812-5
Rotigotine side effect was reported by a Consumer or non-health professional from JAPAN on Feb 26, 2009. Female patient was diagnosed with parkinson's disease  and was treated with Rotigotine. After drug was administered, patient experienced the following side effects: epistaxis. Rotigotine dosage: (4.5 MG TRANSDERMAL) ; (9 MG TRANSDERMAL) ; (13.5 MG TRANSDERMAL). During the same period patient was treated with OMEPRAZOLE, MAGNESIUM OXIDE, ANTIFUNGALS, ETIZOLAM, NABUMETONE, KETOPROFEN. Patient was hospitalized. Patient recovered.